Our identification of TP53, MAPKAPK5, and HLA-G as MAMs-related biomarkers provides novel insights into how MAM dysfunction contributes to AF pathogenesis, particularly the intersection of MAM dysfunction, immune dysregulation, and atrial remodeling. Here, SGCG is linked to atrial fibrillation.